International Journal of Cancer Management

Published by: Kowsar

Analyzing the Long-Term Survival of Patients with Colorectal Cancer: A Study Using Parametric Non-Mixture Cure Rate Models

Mehdi Azizmohammad Looha 1 , Elaheh Zarean 2 , Mohamad Amin Pourhoseingholi 3 , Seyyed Vahid Hosseini 4 , Tara Azimi 5 and Soheila Khodakarim 6 , *
Authors Information
1 Department of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Modeling in Health Research Center, School of Public Health, Department of Epidemiology and Biostatistics, Shahrekord University of Medical Sciences, Shahrekord, Iran
3 Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
5 School of Public Health, University of Alberta, Edmonton, Alberta, Canada
6 Department of Epidemiology, School of Public Health, School of Paramedical Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: September 2018, 11 (9); e81681
  • Published Online: September 18, 2018
  • Article Type: Research Article
  • Received: July 3, 2018
  • Revised: August 21, 2018
  • Accepted: August 25, 2018
  • DOI: 10.5812/ijcm.81681

To Cite: Azizmohammad Looha M, Zarean E , Pourhoseingholi M A, Hosseini S V, Azimi T, et al. Analyzing the Long-Term Survival of Patients with Colorectal Cancer: A Study Using Parametric Non-Mixture Cure Rate Models, Int J Cancer Manag. 2018 ; 11(9):e81681. doi: 10.5812/ijcm.81681.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Sadjadi A, Nouraie M, Ghorbani A, Alimohammadian M, Malekzadeh R. Epidemiology of breast cancer in the Islamic Republic of Iran: First results from a population-based cancer registry. East Mediterr Health J. 2009;15(6):1426-31. [PubMed: 20218134].
  • 2. Mokarian F, Ramezani MA, Heydari K, Tabatabaeian M, Tavazohi H. Epidemiology and trend of cancer in Isfahan 2005-2010. J Res Med Sci. 2011;16(9):1228-33. [PubMed: 22973394]. [PubMed Central: PMC3430050].
  • 3. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683-91. doi: 10.1136/gutjnl-2015-310912. [PubMed: 26818619].
  • 4. Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N Engl J Med. 2006;355(24):2551-7. doi: 10.1056/NEJMcp063038. [PubMed: 17167138].
  • 5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96. doi: 10.3322/CA.2007.0010. [PubMed: 18287387].
  • 6. Azadeh S, Moghimi-Dehkordi B, Fatem SR, Pourhoseingholi MA, Ghiasi S, Zali MR. Colorectal cancer in Iran: An epidemiological study. Asian Pac J Cancer Prev. 2008;9(1):123-6. [PubMed: 18439090].
  • 7. Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FS. Mortality trends of gastrointestinal cancers in Iranian population. Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S52-7. [PubMed: 24834288]. [PubMed Central: PMC4017539].
  • 8. Allemani C, Rachet B, Weir HK, Richardson LC, Lepage C, Faivre J, et al. Colorectal cancer survival in the USA and Europe: A CONCORD high-resolution study. BMJ Open. 2013;3(9). e003055. doi: 10.1136/bmjopen-2013-003055. [PubMed: 24022388]. [PubMed Central: PMC3773629].
  • 9. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ. 2000;321(7264):805-8. [PubMed: 11009523]. [PubMed Central: PMC1118620].
  • 10. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1695-8. doi: 10.1158/1055-9965.EPI-09-0186. [PubMed: 19505901].
  • 11. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59(6):366-78. doi: 10.3322/caac.20038. [PubMed: 19897840].
  • 12. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi: 10.1002/ijc.29210. [PubMed: 25220842].
  • 13. Shin A, Jung KW, Won YJ. Colorectal cancer mortality in Hong Kong of China, Japan, South Korea, and Singapore. World J Gastroenterol. 2013;19(7):979-83. doi: 10.3748/wjg.v19.i7.979. [PubMed: 23467631]. [PubMed Central: PMC3582009].
  • 14. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R. Epidemiology and molecular genetics of colorectal cancer in iran: A review. Arch Iran Med. 2009;12(2):161-9. [PubMed: 19249887].
  • 15. Ait Ouakrim D, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, et al. Trends in colorectal cancer mortality in Europe: Retrospective analysis of the WHO mortality database. BMJ. 2015;351:h4970. doi: 10.1136/bmj.h4970. [PubMed: 26442928]. [PubMed Central: PMC4595561].
  • 16. Sung JJ, Lau JY, Goh KL, Leung WK; Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: Implications for screening. Lancet Oncol. 2005;6(11):871-6. doi: 10.1016/S1470-2045(05)70422-8. [PubMed: 16257795].
  • 17. Dianatinasab M, Ghaem H, Rezaianzadeh A, Hosseini SV, Khazraei H. Colorectal cancer mortality in Shiraz, Iran. Asian Pac J Cancer Prev. 2016;17(8):4101-5. [PubMed: 27644668].
  • 18. Lee J, Jeon JY, Meyerhardt JA. Diet and lifestyle in survivors of colorectal cancer. Hematol Oncol Clin North Am. 2015;29(1):1-27. doi: 10.1016/j.hoc.2014.09.005. [PubMed: 25475570]. [PubMed Central: PMC4258898].
  • 19. Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis. 2008;23(7):683-8. doi: 10.1007/s00384-008-0463-7. [PubMed: 18330578].
  • 20. Moradi A, Khayamzadeh M, Guya M, Mirzaei HR, Salmanian R, Rakhsha A, et al. Survival of colorectal cancer in Iran. Asian Pac J Cancer Prev. 2009;10(4):583-6. [PubMed: 19827873].
  • 21. Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007;8(3):576-94. doi: 10.1093/biostatistics/kxl030. [PubMed: 17021277].
  • 22. Gauci D, Allemani C, Woods L. Population-level cure of colorectal cancer in Malta: An analysis of patients diagnosed between 1995 and 2004. Cancer Epidemiol. 2016;42:32-8. doi: 10.1016/j.canep.2016.03.001. [PubMed: 26999401].
  • 23. Zarean E, Yaseri M, Mahmoodi M, Entezar Mahdi R. [Factors affecting long-term survival rate with cure fraction using the mixture cure cox model in patients with gastric cancer in East-Azerbaijan province, Iran]. J Sch Public Health Institute Public Health Res (SJSPH). 2018;15(4):337-50. Persian.
  • 24. Zarean E, Azizmohammad Looha M, Amini P, Mahmoudi M, Azimi T. Factors affecting long-survival of patients with esophageal cancer using non-mixture cure fraction model. Asian Pac J Cancer Prev. 2018;19(6):1677-83. doi: 10.22034/APJCP.2018.19.6.1677. [PubMed: 29938465]. [PubMed Central: PMC6103597].
  • 25. Andersson TM, Dickman PW, Eloranta S, Lambert PC. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol. 2011;11:96. doi: 10.1186/1471-2288-11-96. [PubMed: 21696598]. [PubMed Central: PMC3145604].
  • 26. Amico M, Van Keilegom I. Cure models in survival analysis. Annu Rev Stat Appl. 2018;5(1):311-42. doi: 10.1146/annurev-statistics-031017-100101.
  • 27. Chen MH, Ibrahim JG, Sinha D. A new bayesian model for survival data with a surviving fraction. J Am Stat Assoc. 1999;94(447):909-19. doi: 10.1080/01621459.1999.10474196.
  • 28. McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg. 2003;90(6):711-5. doi: 10.1002/bjs.4098. [PubMed: 12808619].
  • 29. Amri R, Stronks K, Bordeianou LG, Sylla P, Berger DL. Gender and ethnic disparities in colon cancer presentation and outcomes in a US universal health care setting. J Surg Oncol. 2014;109(7):645-51. doi: 10.1002/jso.23567. [PubMed: 24474677].
  • 30. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union internationale contre le cancer and the American joint committee on cancer. Cancer. 1997;80(9):1803-4. [PubMed: 9351551].
  • 31. Oh HS, Chung HJ, Kim HK, Choi JS. Differences in overall survival when colorectal cancer patients are stratified into new TNM staging strategy. Cancer Res Treat. 2007;39(2):61-4. doi: 10.4143/crt.2007.39.2.61. [PubMed: 19746212]. [PubMed Central: PMC2739317].
  • 32. Li Q, Cai G, Li D, Wang Y, Zhuo C, Cai S. Better long-term survival in young patients with non-metastatic colorectal cancer after surgery, an analysis of 69,835 patients in SEER database. PLoS One. 2014;9(4). e93756. doi: 10.1371/journal.pone.0093756. [PubMed: 24699879]. [PubMed Central: PMC3974782].
  • 33. Chu QD, Zhou M, Medeiros KL, Peddi P, Kavanaugh M, Wu XC. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy. BMC Cancer. 2016;16:460. doi: 10.1186/s12885-016-2446-3. [PubMed: 27412163]. [PubMed Central: PMC4944507].
  • 34. Obrand DI, Gordon PH. Continued change in the distribution of colorectal carcinoma. Br J Surg. 1998;85(2):246-8. doi: 10.1046/j.1365-2168.1998.00507.x. [PubMed: 9501827].
  • 35. Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, et al. Prognostic impact of tumor location in stage IV colon cancer: A propensity score analysis in a multicenter study. Int J Surg. 2014;12(9):925-30. doi: 10.1016/j.ijsu.2014.07.270. [PubMed: 25091400].
  • 36. Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15(9):2388-94. doi: 10.1245/s10434-008-0015-y. [PubMed: 18622647]. [PubMed Central: PMC3072702].
  • 37. Jess P, Hansen IO, Gamborg M, Jess T, Danish Colorectal Cancer G. A nationwide danish cohort study challenging the categorisation into right-sided and left-sided colon cancer. BMJ Open. 2013;3(5). doi: 10.1136/bmjopen-2013-002608. [PubMed: 23793665]. [PubMed Central: PMC3657647].
  • 38. Ishihara S, Watanabe T, Akahane T, Shimada R, Horiuchi A, Shibuya H, et al. Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon. Int J Colorectal Dis. 2012;27(3):371-9. doi: 10.1007/s00384-011-1343-0. [PubMed: 22052041].
  • 39. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009;27(31):5131-7. doi: 10.1200/JCO.2009.22.4949. [PubMed: 19738119]. [PubMed Central: PMC2773472].
  • 40. Poeschl EM, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, Rehak P, et al. Perineural invasion: Correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer. J Clin Oncol. 2010;28(21):e358-60. author reply e361-2. doi: 10.1200/JCO.2009.27.3581. [PubMed: 20385977].
  • 41. Yamada S, Fujii T, Hirakawa A, Kanda M, Sugimoto H, Kodera Y. Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer. Langenbecks Arch Surg. 2016;401(8):1143-52. doi: 10.1007/s00423-016-1412-5. [PubMed: 27048402].
  • 42. Bhatti I, Peacock O, Awan AK, Semeraro D, Larvin M, Hall RI. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma. World J Surg. 2010;34(4):768-75. doi: 10.1007/s00268-009-0336-4. [PubMed: 20052471].
  • 43. Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis. 2009;24(11):1297-302. doi: 10.1007/s00384-009-0738-7. [PubMed: 19479270].
  • 44. Zare Mirzaei A, Abdorrazaghi F, Lotfi M, Kazemi Nejad B, Shayanfar N. Prognostic value of lymph node ratio in comparison to lymph node metastases in stage III colon cancer. Iran J Pathol. 2015;10(2):127-35. [PubMed: 26351473]. [PubMed Central: PMC4539757].
  • 45. Peschaud F, Benoist S, Julie C, Beauchet A, Penna C, Rougier P, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg. 2008;248(6):1067-73. doi: 10.1097/SLA.0b013e31818842ec. [PubMed: 19092352].
  • 46. Rausei S, Iovino D, Tenconi S, Mangano A, Inversini D, Boni L, et al. Impact of lymph node ratio on survival of colorectal cancer patients. Int J Surg. 2013;11 Suppl 1:S95-9. doi: 10.1016/S1743-9191(13)60026-6. [PubMed: 24380564].
  • 47. Jun KH, Jung H, Baek JM, Chin HM, Park WB. Does tumor size have an impact on gastric cancer? A single institute experience. Langenbecks Arch Surg. 2009;394(4):631-5. doi: 10.1007/s00423-008-0417-0. [PubMed: 18791731].
  • 48. Kornprat P, Pollheimer MJ, Lindtner RA, Schlemmer A, Rehak P, Langner C. Value of tumor size as a prognostic variable in colorectal cancer: A critical reappraisal. Am J Clin Oncol. 2011;34(1):43-9. doi: 10.1097/COC.0b013e3181cae8dd. [PubMed: 20101166].
  • 49. Ostenfeld EB, Norgaard M, Thomsen RW, Iversen LH, Jacobsen JB, Sogaard M. Comorbidity and survival of danish patients with colon and rectal cancer from 2000-2011: A population-based cohort study. Clin Epidemiol. 2013;5(Suppl 1):65-74. doi: 10.2147/CLEP.S47154. [PubMed: 24227924]. [PubMed Central: PMC3820479].
  • 50. van Eeghen EE, Bakker SD, van Bochove A, Loffeld RJ. Impact of age and comorbidity on survival in colorectal cancer. J Gastrointest Oncol. 2015;6(6):605-12. doi: 10.3978/j.issn.2078-6891.2015.070. [PubMed: 26697191]. [PubMed Central: PMC4671847].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments